Nicox S.A. (OTCMKTS:NICXF – Get Free Report) was the target of a significant drop in short interest in the month of November. As of November 30th, there was short interest totalling 600 shares, a drop of 40.0% from the November 15th total of 1,000 shares. Based on an average daily volume of 0 shares, the […]
Nicox S.A. (OTCMKTS:NICXF – Get Rating) saw a significant growth in short interest in the month of March. As of March 31st, there was short interest totalling 1,000 shares, a growth of 900.0% from the March 15th total of 100 shares. Based on an average trading volume of 200 shares, the short-interest ratio is presently […]
Nicox S.A. (OTCMKTS:NICXF – Get Rating) – Equities research analysts at HC Wainwright boosted their Q1 2023 EPS estimates for Nicox in a research report issued to clients and investors on Tuesday, March 21st. HC Wainwright analyst R. Selvaraju now forecasts that the company will post earnings of ($0.12) per share for the quarter, up […]
Nicox (OTCMKTS:NICXF – Get Rating) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a report released on Wednesday, Zacks.com reports. According to Zacks, “Nicox S.A. is an international ophthalmology company developing innovative solutions to help maintain vision and improve ocular health. By leveraging their proprietary expertise in nitric […]
Nicox (OTCMKTS:NICXF – Get Rating) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a report released on Tuesday, Zacks.com reports. The brokerage currently has a $2.00 price target on the stock. Zacks Investment Research‘s price objective indicates a potential upside of 6.95% from the company’s current price. According […]